Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Anderson David HugoDirector |  NWNNorthwest Natural Holding CoOpen-market sale · 10b5-1 plan | SELL | $73K 1,500 sh |
| Oct 21, 2026 traded Oct 19, 2026 |
| 4 | Bitterman KevinDirector |  IRONDisc Medicine, Inc.Open-market sale · 10b5-1 plan | SELL | $229K 2,869 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 4 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $191K 2,388 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 3 | Garefis AmyEVP, Chief People Officer |  ZIPZIPRECRUITER, INC.Open-market sale · 10b5-1 plan | SELL | $36K 7,879 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $2,485 100 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 3 | Piscitelli DominicChief Financial Officer |  ORICOric Pharmaceuticals, Inc.Option exercise · 10b5-1 plan | M | — 14.0K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $150K 5,882 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 1 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $4,397 55 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 1 | Malady KyleEVP and Group CEO-VZ Business |  VZVERIZON COMMUNICATIONS INCOpen-market sale · 10b5-1 plan | SELL | $49K 1,100 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 1 | Ghamsari NimaDirector, HEAD OF BLEND |  BLNDBlend Labs, Inc.Open-market sale · 10b5-1 plan | SELL | $26K 27.8K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $151K 5,999 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Derivative conversion · 10b5-1 plan | C | — 4,135 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | — 23.3K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 4,172 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | — 17.9K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 4,172 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | — 5,266 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 21, 2026 traded Oct 21, 2026 |
| 0 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner |  STRRStar Equity Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $9,110 1,000 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | $90K 17.9K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Option exercise · 10b5-1 plan | M | — 3,000 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 21, 2026 traded Oct 21, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 4,135 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 |  Slootman FrankDirector | SNOWSnowflake Inc. Option exercise · 10b5-1 plan | M | — 300.0K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 |  Silbermann BenjaminDirector, 10% Owner |  PINSPINTEREST, INC.Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Oct 21, 2026 traded Oct 21, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | PINSPINTEREST, INC. Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 0 | Collins Helen LouiseCHIEF MEDICAL OFFICER |  ELVNEnliven Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $12K 5,000 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Hall John TDirector, Chief Executive Officer | INTAIntapp, Inc. Option exercise · 10b5-1 plan | M | $22K 3,000 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner | STRRStar Equity Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $9,100 1,000 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 0 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner | STRRStar Equity Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $8,990 1,000 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 0 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 266 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | $125K 23.3K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 4,135 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 4,135 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 5,000 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | $28K 5,266 sh | Oct 21, 2026 traded Oct 19, 2026 |
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K